Menovo(SH:603538)2025-04-29 10:28Financial Performance - The company's operating revenue for Q1 2025 was CNY 276,483,125.97, representing a 5.22% increase compared to CNY 262,766,361.43 in the same period last year[3]. - Net profit attributable to shareholders increased by 51.12% to CNY 21,221,727.07 from CNY 14,043,259.71 year-on-year[3]. - Basic and diluted earnings per share rose by 42.86% to CNY 0.10 from CNY 0.07 in the previous year[3]. - The company reported a decrease of 19.02% in net profit attributable to shareholders after deducting non-recurring gains and losses, totaling CNY 16,622,403.34 compared to CNY 20,527,312.45 last year[3]. - Net profit for Q1 2025 was ¥23,190,551.99, representing a 47.0% increase from ¥15,770,884.38 in Q1 2024[17]. - Earnings per share for Q1 2025 were ¥0.10, compared to ¥0.07 in Q1 2024, indicating a growth of 42.9%[17]. Cash Flow and Liquidity - The net cash flow from operating activities improved to -CNY 25,479,750.86, a significant reduction from -CNY 54,422,979.34 in the same period last year[3]. - Cash inflow from operating activities for Q1 2025 was $366,592,076.69, an increase of 16.6% compared to $314,422,241.75 in Q1 2024[21]. - Net cash outflow from operating activities for Q1 2025 was -$25,479,750.86, an improvement from -$54,422,979.34 in Q1 2024[21]. - The net increase in cash and cash equivalents for Q1 2025 was $67,582,405.59, compared to a decrease of -$42,881,422.30 in Q1 2024[22]. - The ending balance of cash and cash equivalents for Q1 2025 was $380,530,147.67, a significant increase from $231,088,104.66 in Q1 2024[22]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,644,853,669.43, a slight decrease of 0.14% from CNY 4,651,221,247.28 at the end of the previous year[4]. - The total liabilities increased from RMB 1,080,000,000 to RMB 1,200,000,000, indicating a growth of approximately 11.1%[13]. - Short-term borrowings increased significantly from RMB 479,056,993.19 to RMB 659,176,824.56, representing a rise of about 37.5%[13]. - The total liabilities decreased slightly to ¥2,324,744,198.14 in Q1 2025 from ¥2,359,778,651.01 in Q1 2024[16]. - The total equity increased to ¥2,320,109,471.29 in Q1 2025, up from ¥2,291,442,596.27 in Q1 2024, showing a growth of 1.2%[16]. Expenses - Sales expenses surged by 61.50%, primarily due to the ongoing expansion of domestic business and increased share-based payment allocation[6]. - Financial expenses skyrocketed by 216.95%, attributed to the capitalization of interest expenses related to convertible bonds[6]. - Total operating costs for Q1 2025 were ¥258,654,126.54, up from ¥239,538,003.21 in Q1 2024, reflecting a year-over-year increase of 7.9%[16]. - Research and development expenses for Q1 2025 were ¥15,012,233.31, slightly down from ¥15,827,004.16 in Q1 2024[16]. Investments and Future Plans - The company reported an investment income of ¥3,061,477.94 in Q1 2025, a significant recovery from a loss of ¥13,589,352.18 in Q1 2024[16]. - The company plans to continue expanding its market presence and investing in new product development to drive future growth[19].